Showing 1 - 3 results of 3 for search 'C. Shikuma', query time: 0.03s Refine Results
  1. 1
    A modified TZM-bl assay (MoCo-TZA) documents replication-competent HIV in circulating monocytes despite 2 years of antiretroviral therapy initiated early during acute infection

    A modified TZM-bl assay (MoCo-TZA) documents replication-competent HIV in circulating monocytes despite 2 years of antiretroviral therapy initiated early during acute infection by B. Mitchell, E. Laws, R. Paul, S. Vasan, E. Kroon, V. Valcour, S. Spudich, C. Shikuma, J. Ananworanich, L. Ndhlovu

    Published 2019-12-01
    Get full text
    Article
  2. 2
    CD4+ T-cells expressing negative checkpoint receptors are associated with decreased mitochondrial oxidative phosphorylation in chronic HIV

    CD4+ T-cells expressing negative checkpoint receptors are associated with decreased mitochondrial oxidative phosphorylation in chronic HIV by L.M. Gangcuangco, C. Shikuma, B. Mitchell, S. Bowler, G. Chew, L. Ndhlovu, K. Kallianpur, M. Gerschenson, S. Souza, D. Chow

    Published 2019-07-01
    Get full text
    Article
  3. 3
    Cenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy

    Cenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy by S. Bowler, C. Siriwardhana, B. L. Mitchell, M. L. D’Antoni, D. Ogata-Arakaki, S. Souza, R. Yee, L. M. A. Gangcuangco, D. C. Chow, L. C. Ndhlovu, C. Shikuma

    Published 2019-09-01
    Get full text
    Article

Search Tools: